ArticleJournal of thrombosis and haemostasis : JTH2022

A novel next-generation FVIIIa mimetic, Mim8, has a favorable safety profile and displays potent pharmacodynamic effects: Results from safety studies in cynomolgus monkeys.

Brian Lauritzen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.